Cargando…
Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
Breast cancer stem cells (BCSCs) have been considered responsible for cancer progression, recurrence, metastasis and drug resistance. However, the mechanisms by which cells acquire self‐renewal and chemoresistance properties are remaining largely unclear. Herein, we evaluated the role of miR‐708 and...
Autores principales: | Tan, Weige, Tang, Hailin, Jiang, Xinhua, Ye, Feng, Huang, Lili, Shi, Dingbo, Li, Laisheng, Huang, Xiaojia, Li, Li, Xie, Xiaoming, Xie, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714171/ https://www.ncbi.nlm.nih.gov/pubmed/31273952 http://dx.doi.org/10.1111/jcmm.14462 |
Ejemplares similares
-
MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013) -
Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013) -
MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
por: Huang, Wei, et al.
Publicado: (2018) -
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
por: Liu, Peng, et al.
Publicado: (2016) -
Synergistic effects of miR-708-5p and miR-708-3p accelerate the progression of osteoporosis
por: Wang, Ruran, et al.
Publicado: (2020)